Given the cost of caring for an aging population in an era of high-tech but expensive treatments, it's no wonder healthcare reform occupies a lot of space in political conversations. But the devil is ...
Some Canadian public-health researchers have argued that the nation’s drug dealers, far from being a public scourge, are central to the cause of “harm reduction,” and that drug criminalization makes ...
Between 2022-2025, Joel Lexchin received payments for writing a brief for a legal firm on the role of promotion in generating prescriptions for opioids, for being on a panel about pharmacare and for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results